Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 5/20 | 0.52 |
| ▸ | PPARG | P37231 | 4/20 | 0.49 |
| ▸ | ACE | P12821 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | CTSS | P25774 | 4/20 | 0.47 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.47 |
| ▸ | SYK | P43405 | 1/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 2/20 | 0.46 |
| ▸ | PPARD | Q03181 | 2/20 | 0.45 |
| ▸ | CTSL | P07711 | 1/20 | 0.45 |
| ▸ | CTSB | P07858 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL203720 | 0.92 | PPARA (0.56) | PPARAPPARGACECTSSFOLH1 | |
| SCHEMBL2707177 | 0.92 | PPARA (0.56) | PPARAPPARGACECTSSFOLH1 | |
| SCHEMBL957159 | 0.92 | PPARA (0.56) | PPARAPPARGACECTSSFOLH1 | |
| SCHEMBL2899548 | 0.85 | PPARA (0.54) | PPARAPPARGACECTSSSYK | |
| SCHEMBL10883348 | 0.85 | PPARA (0.54) | PPARAPPARGACECTSSSYK | |
| SCHEMBL10054776 | 0.85 | PPARA (0.56) | PPARAPPARGACECTSSSYK | |
| SCHEMBL27578688 | 0.85 | PPARA (0.56) | PPARAPPARGACECTSSSYK | |
| SCHEMBL1517760 | 0.84 | PPARA (0.55) | PPARAPPARGACECTSSSYK | |
| SCHEMBL14674671 | 0.84 | CTSS (0.54) | PPARAPPARGCTSSSYKITGB3 | |
| SCHEMBL3817109 | 0.84 | PPARA (0.55) | PPARAPPARGACECTSSSYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080275139-A1 | Cyclodextrin-Containing Polymers and Uses Thereof | CAPSUTECH LTD. (IL) | 2008-11-06 | — | — | US | disclosed |
| EP-1976546-A2 | CYCLODEXTRIN-CONTAINING POLYMERS AND USES THEREOF | Capsutech Ltd. (IL) | 2008-10-08 | — | — | EP | disclosed |
| WO-2007072481-A2 | CYCLODEXTRIN-CONTAINING POLYMERS AND USES THEREOF | CAPSUTECH LTD. (IL) | 2007-06-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080275139-A1 | Cyclodextrin-Containing Polymers and Uses Thereof | IAPP, RNGTT, DDOST | PPARA 2035/4885PPARG 3165/4885ACE 2317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.